Skip to main navigation Skip to search Skip to main content

CTU: Investigation of the safety and efficacy of once weekly NNC0519-0130 administered subcutaneously in participants with type 2 diabetes – a dose finding study

  • Preda, Veronica (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleNN9541-4945
AcronymNN9541-4945
StatusActive
Effective start/end date2/05/24 → 27/03/29